Research Topic · Peer-Reviewed

Adeno-associated Viruses

Adeno-associated viruses (AAVs) are small, non-pathogenic viruses that can be used as gene-therapy vectors. This means they can be used to deliver genetic material into cells to treat genetic diseases and disorders. AAVs have been used to treat a wide range of inherited diseases and have become the mainstay of gene …

📚 0 peer-reviewed articles cited 🔖 ISSN 2691-8862 🗓 Reviewed June 2026

Overview

Adeno-associated viruses (AAVs) are small, non-pathogenic viruses that can be used as gene-therapy vectors. This means they can be used to deliver genetic material into cells to treat genetic diseases and disorders. AAVs have been used to treat a wide range of inherited diseases and have become the mainstay of gene therapy, due to their efficiency and safety compared to other virus vectors. They are particularly useful for delivering the genetic material required for gene therapy in hard-to-reach organs and tissues. AAVs are being used to develop therapeutic treatments for ailments including hemophilia, inherited retinal degeneration, limb girdle muscular dystrophy, cystic fibrosis, Huntington’s disease, and more. AAVs also have potential applications in cancer immunotherapy and vaccine delivery.

Research published in this journal

No peer-reviewed research on this exact topic has been published in Current Viruses and Treatment Methodologies yet. Browse the journal →

Editorial oversight

Curated from peer-reviewed research published in Current Viruses and Treatment Methodologies (ISSN 2691-8862).

Journal editorial board
Dr. Anantha Harijith · United States

This page summarises published research for orientation; it is not medical or professional advice.